CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 11 No. 11
 

A New Tool in the Study of Cancer

November 1, 1997

With a few clicks of a computer mouse, scientists now can access a free on-line index that will soon show tens of thousands of genes expressed in common cancers, including lung, prostate, colon, breast, and ovarian.

The web site, part of the Cancer Genome Anatomy Project (CGAP), which was developed by the National Cancer Institute (NCI) and National Library of Medicine, offers a new tool to study cancer. Now scientists can click on the CGAP web site from their office computers and submit specific queries about genes expressed during the development of cancer. In response, the CGAP database will sort through its gene index in seconds and provide a list of genes relevant to the query, data that just a few years ago researchers might have contemplated devoting their entire careers to obtain.

Researchers can then go back to the laboratory to investigate more completely the role of these genes or sets of genes and their protein products in cancer. “CGAP highlights the rapid progress that can be made when technology development and scientific discovery work hand in hand,” said Vice President Al Gore, who officially launched the CGAP web site at a ceremony in Washington, DC. “We hope this project will eventually have an impact on every aspect of the fight against cancer.”

A Work in Progress

The CGAP home page is located at www.ncbi.nlm.nih.gov/ncicgap. The web site now contains information on thousands of genes in a few cancers, but it will constantly add new data as they become available, making the gene index very much a work in progress over the next few years. All CGAP resources—including cDNA libraries, clones, and sequence data—are publicly accessible to scientists.

“If a gene transcript represented a book, one could think of CGAP as collecting and ordering into individual libraries all of the books that a normal, a precancerous, and a malignant cell prints at one time,” said Klausner. “With further analysis of each library, it will be possible ultimately to read and contrast the full genetic text of a normal cell with that of a cancer cell, critical information in trying to understand the molecular causes of cancer.”

Klausner said the CGAP is employing a new research tool to create many of its cDNA libraries. Called laser capture microdissection, or LCM, the new technique allows researchers to select specific tumor cells for analysis, and assess which genes they are expressing in their environment inside the body.

Lance Liotta, MD, PhD, chief of NCI’s Laboratory of Pathology, said researchers in the past typically have had to spend hours isolating and culturing cells before they were ever able to study the genes and proteins inside them. As a result, the cells often have begun to react to their new laboratory environment, expressing genes differently than they would inside in the body and making analyses difficult.

LCM works on the same, basic aim-and-shoot principle as a camera:

  • A scientist looks through a microscope at a tissue biopsy, which typically contains hundreds of types of cells.
  • Upon spotting a group of interesting cells (normal, precancerous, or cancerous), the scientist presses a button on the side of the microscope. The button activates a laser, which flashes a beam of light that has an intensity slightly greater than a laser pointer.
  • The laser beam passes through the plastic film placed above the tissue sample and focuses onto the cells. In the process, the beam melts the film, causing it to fuse to the underlying cells. When the film is removed, the selected cells are immediately extracted from the plastic and ready for analysis.
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy